rosiglitazone has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Huang, F; Li, Y; Zhang, XK; Zhou, H | 1 |
1 other study(ies) available for rosiglitazone and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Rosiglitazone binds to RXRα to induce RXRα tetramerization and NB4 cell differentiation.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; HEK293 Cells; Humans; Hypoglycemic Agents; Leukemia, Promyelocytic, Acute; Protein Multimerization; Retinoid X Receptor alpha; Rosiglitazone | 2020 |